drugset / Trial / NCT02236247

Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure

NCT02236247

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study aims to compare the I(f) inhibitor ivabradine with placebo as strategy of heart rate control in patients with decompensated heart failure (DHF).

Timeline

Start
2013-05
Primary completion
2017-01
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivabradine Small molecule 5 mg Oral

Indications